Hepatitis B Virus (HBV)

Sitemap

Page 1 of 5 : Next

Posts

Category: Airway Obstruction
- Comparison of PEFR and FEV1 in Patients with Varying Degrees of Airway Obstruction
- Comparison of PEFR and FEV1 in Patients with Varying Degrees of Airway Obstruction: Conclusion
- Comparison of PEFR and FEV1 in Patients with Varying Degrees of Airway Obstruction: Discussion
- Comparison of PEFR and FEV1 in Patients with Varying Degrees of Airway Obstruction: Materials and Methods
- Comparison of PEFR and FEV1 in Patients with Varying Degrees of Airway Obstruction: Results
Category: Airways Diseases
- Epidemiology of Chronic Airways Diseases in Japan
- Epidemiology of Chronic Airways Diseases in Japan: Changes in Mortality From Lung Diseases
- Epidemiology of Chronic Airways Diseases in Japan: Passive smoking
- Epidemiology of Chronic Airways Diseases in Japan: Prevalence of Respiratory Symptoms
Category: Antibiotic Levaquin
- Antibiotic Levaquin may treat even T.B.
Category: Antibiotics
- Ampicillin - the time-tested antibiotic
- Ventolin in children treatment
Category: Antithrombotic Therapy
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Acute Extremity Arterial Insufficiency
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Antithrombotic agents
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Carotid Endarterectomy
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Chronic Extremity Arterial Insufficiency
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Cilostazol
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Clopidogrel
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Conclusion
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Heparin
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Low-dose streptokinase
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Low-intensity oral anticoagulant therapy
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Multicenter trial of thrombolysis
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Oral anticoagulants
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Pentoxifylline
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Percutaneous Transluminal Angioplasty
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Peripheral angioplasty
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Peripheral Vascular Reconstructive Surgery
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Protective effects of aspirin
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Recommendations
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Risk of stroke
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Ticlopidine
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Vascular reconstructions
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Vascular surgeons
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Vein femoral-popliteal bypass
- Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: Vein Grafts and Arterial Prostheses
Category: Aortic Valve Replacement
- Factors Determining In-Hospital or Late Survival after Aortic Valve Replacement
- Factors Determining In-Hospital or Late Survival after Aortic Valve Replacement: Collection of Data and Statistical Analyses
- Factors Determining In-Hospital or Late Survival after Aortic Valve Replacement: Conclusion
- Factors Determining In-Hospital or Late Survival after Aortic Valve Replacement: Late Mortality
- Factors Determining In-Hospital or Late Survival after Aortic Valve Replacement: Outcome
- Factors Determining In-Hospital or Late Survival after Aortic Valve Replacement: Results
- Factors Determining In-Hospital or Late Survival after Aortic Valve Replacement: Survival of Valve
Category: Ascorbic Acid
- Modulation of 72-Kilodalton Type IV Collagenase (Matrix Metalloproteinase-2) by Ascorbic Acid in Cultured Human Amnion-Derived Cells(1)
- Modulation of 72-Kilodalton Type IV Collagenase (Matrix Metalloproteinase-2) by Ascorbic Acid in Cultured Human Amnion-Derived Cells(2)
- Modulation of 72-Kilodalton Type IV Collagenase: DISCUSSION(1)
- Modulation of 72-Kilodalton Type IV Collagenase: DISCUSSION(2)
- Modulation of 72-Kilodalton Type IV Collagenase: MATERIALS AND METHODS(1)
- Modulation of 72-Kilodalton Type IV Collagenase: MATERIALS AND METHODS(2)
- Modulation of 72-Kilodalton Type IV Collagenase: MATERIALS AND METHODS(3)
- Modulation of 72-Kilodalton Type IV Collagenase: RESULTS(1)
- Modulation of 72-Kilodalton Type IV Collagenase: RESULTS(2)
Category: Asthma
- Accuracy of Asthma Mortality in France
- Anesthesia and Airway Obstruction
- Asthma Care Practices in Chicago-Area Emergency Departments
- Asthma Care Practices in Chicago-Area Emergency Departments: Asthma Treatment
- Asthma Care Practices in Chicago-Area Emergency Departments: Conclusion
- Asthma Care Practices in Chicago-Area Emergency Departments: Discussion
- Asthma Care Practices in Chicago-Area Emergency Departments: Materials and Methods
- Asthma Care Practices in Chicago-Area Emergency Departments: Outcome
- Asthma Care Practices in Chicago-Area Emergency Departments: Practice Patterns in Relation to Guidelines
- Asthma Care Practices in Chicago-Area Emergency Departments: Results
- Asthma Care Practices in Chicago-Area Emergency Departments: Statistical Analysis
- Asthma Care Practices in Chicago-Area Emergency Departments: Survey Population
- Asthma in Pregnancy
- Asthma in Pregnancy: DISCUSSION
- Asthma in Pregnancy: METHODS
- Asthma in Pregnancy: RESULTS
- Bronchodilating Effect of Intravenous Magnesium Sulfate in Acute Severe Bronchial Asthma
- Bronchodilating Effect of Intravenous Magnesium Sulfate in Acute Severe Bronchial Asthma: DISCUSSION
- Bronchodilating Effect of Intravenous Magnesium Sulfate in Acute Severe Bronchial Asthma: METHODS
- Bronchodilating Effect of Intravenous Magnesium Sulfate in Acute Severe Bronchial Asthma: RESULTS
- Comparison of Responses to Methacholine and Cold Air in Patients Suspected of Having Asthma
- Comparison of Responses to Methacholine and Cold Air in Patients Suspected of Having Asthma: Conclusion
- Comparison of Responses to Methacholine and Cold Air in Patients Suspected of Having Asthma: Discussion
- Comparison of Responses to Methacholine and Cold Air in Patients Suspected of Having Asthma: Episode of hyperventilation
- Comparison of Responses to Methacholine and Cold Air in Patients Suspected of Having Asthma: Material and Methods
- Comparison of Responses to Methacholine and Cold Air in Patients Suspected of Having Asthma: Outcome
- Comparison of Responses to Methacholine and Cold Air in Patients Suspected of Having Asthma: Positive responses
- Comparison of Responses to Methacholine and Cold Air in Patients Suspected of Having Asthma: Results
- Effect and directions for using of Flovent inhaler
- Effect of Endobronchial Radiation Therapy on Malignant Bronchial Obstruction
- Effect of Endobronchial Radiation Therapy on Malignant Bronchial Obstruction: DISCUSSION
- Effect of Endobronchial Radiation Therapy on Malignant Bronchial Obstruction: RESULTS
- Flovent Inhaler
- Ketotifen in the Prophylaxis of Extrinsic Bronchial Asthma
- Ketotifen in the Prophylaxis of Extrinsic Bronchial Asthma: Conclusion
- Ketotifen in the Prophylaxis of Extrinsic Bronchial Asthma: Design of Study
- Ketotifen in the Prophylaxis of Extrinsic Bronchial Asthma: Discussion
- Ketotifen in the Prophylaxis of Extrinsic Bronchial Asthma: Efficacy
- Ketotifen in the Prophylaxis of Extrinsic Bronchial Asthma: Results
- Persistence of Toluene Diisocyanate-Induced Asthma Despite Negligible Workplace Exposures
- Persistence of Toluene Diisocyanate-Induced Asthma Despite Negligible Workplace Exposures: DISCUSSION
- Persistence of Toluene Diisocyanate-Induced Asthma Despite Negligible Workplace Exposures: MATERIALS AND METHODS
- Persistence of Toluene Diisocyanate-Induced Asthma Despite Negligible Workplace Exposures: MATERIALS AND METHODS part 2
- Persistence of Toluene Diisocyanate-Induced Asthma Despite Negligible Workplace Exposures: RESULTS
- Persistence of Toluene Diisocyanate-Induced Asthma Despite Negligible Workplace Exposures: RESULTS part 2
- Relationship Between Airway Obstruction and Respiratory Symptoms in Adult Asthmatics
- Relationship Between Airway Obstruction and Respiratory Symptoms in Adult Asthmatics: Conclusion
- Relationship Between Airway Obstruction and Respiratory Symptoms in Adult Asthmatics: Discussion
- Relationship Between Airway Obstruction and Respiratory Symptoms in Adult Asthmatics: Materials and Methods
- Relationship Between Airway Obstruction and Respiratory Symptoms in Adult Asthmatics: Outcome
- Relationship Between Airway Obstruction and Respiratory Symptoms in Adult Asthmatics: Results
- Your first asthma inhaler
Category: Biogenesis
- Acrosome Biogenesis in the Hamster: DISCUSSION(1)
- Acrosome Biogenesis in the Hamster: DISCUSSION(2)
- Acrosome Biogenesis in the Hamster: DISCUSSION(3)
- Acrosome Biogenesis in the Hamster: DISCUSSION(4)
- Acrosome Biogenesis in the Hamster: DISCUSSION(5)
- Acrosome Biogenesis in the Hamster: MATERIALS AND METHODS(1)
- Acrosome Biogenesis in the Hamster: MATERIALS AND METHODS(2)
- Acrosome Biogenesis in the Hamster: MATERIALS AND METHODS(3)
- Acrosome Biogenesis in the Hamster: MATERIALS AND METHODS(4)
- Acrosome Biogenesis in the Hamster: MATERIALS AND METHODS(5)
- Acrosome Biogenesis in the Hamster: RESULTS(1)
- Acrosome Biogenesis in the Hamster: RESULTS(2)
- Acrosome Biogenesis in the Hamster: RESULTS(3)
- Acrosome Biogenesis in the Hamster: RESULTS(4)
- Acrosome Biogenesis in the Hamster: RESULTS(5)
- Acrosome Biogenesis in the Hamster: RESULTS(6)
- Acrosome Biogenesis in the Hamster: RESULTS(7)
- Acrosome Biogenesis in the Hamster: Ultrastructurally Distinct Matrix Regions Are Assembled from a Common Precursor Polypeptide(1)
- Acrosome Biogenesis in the Hamster: Ultrastructurally Distinct Matrix Regions Are Assembled from a Common Precursor Polypeptide(2)
Category: Blood pressure
- TREATMENT OF DIFFICULT-TO-CONTROL BLOOD PRESSURE
- TREATMENT OF DIFFICULT-TO-CONTROL BLOOD PRESSURE: DISCUSSION
- TREATMENT OF DIFFICULT-TO-CONTROL BLOOD PRESSURE: METHODS
- TREATMENT OF DIFFICULT-TO-CONTROL BLOOD PRESSURE: RESULTS
Category: Bone
- Bone mineral density measurement in children and adolescents
- Bone mineral density measurement in children and adolescents: Novelties in measurement programs
- Bone mineral density measurement in children and adolescents: Quantitative Ultrasound measurement (QUS)
- FTIR microspectroscopic analysis: future perspectives
- FTIR microspectroscopic analysis: future perspectives. Bone mineral
- FTIR microspectroscopic analysis: future perspectives. Infrared microspectroscopy, bone strength & osteoporosis
- FTIR microspectroscopic analysis: future perspectives. Infrared spectroscopy
Category: Breathing
- Canadian Neighbor Pharmacy: Intermittent Positive Pressure Breathing in Patients with Respiratory Muscle Weakness
Category: Bronchoscopy
- Rapid Mucosal Absorption of Topical Lidocaine During Bronchoscopy in the Presence of Oral Candidiasis
- Rapid Mucosal Absorption of Topical Lidocaine During Bronchoscopy in the Presence of Oral Candidiasis: Conclusion
- Rapid Mucosal Absorption of Topical Lidocaine During Bronchoscopy in the Presence of Oral Candidiasis: Discussion
Category: Calcium
- Atorvastatin calcium: A new HMG-CoA reductase inhibitor(1)
- Atorvastatin calcium: A new HMG-CoA reductase inhibitor(2) / asthma inhalers
- Atorvastatin calcium: A new HMG-CoA reductase inhibitor(3)
- Atorvastatin calcium: A new HMG-CoA reductase inhibitor(4)
- Atorvastatin calcium: CONCLUSIONS(1)
- Atorvastatin calcium: CONCLUSIONS(2)
- Atorvastatin calcium: CONCLUSIONS(3)
- Atorvastatin calcium: DOSAGE(1)
- Atorvastatin calcium: DOSAGE(2)
- Atorvastatin calcium: EFFICACY(1)
- Atorvastatin calcium: EFFICACY(10)
- Atorvastatin calcium: EFFICACY(2)
- Atorvastatin calcium: EFFICACY(3)
- Atorvastatin calcium: EFFICACY(4)
- Atorvastatin calcium: EFFICACY(5)
- Atorvastatin calcium: EFFICACY(6)
- Atorvastatin calcium: EFFICACY(7)
- Atorvastatin calcium: EFFICACY(8)
- Atorvastatin calcium: EFFICACY(9)
- Atorvastatin calcium: FUTURE STUDIES(1)
- Atorvastatin calcium: FUTURE STUDIES(2)
- Atorvastatin calcium: MECHANISM OF ACTION
- Atorvastatin calcium: OTHER ACTIONS
- Atorvastatin calcium: PHARMACOKINETICS
- Atorvastatin calcium: PLACE IN THERAPY(1)
- Atorvastatin calcium: PLACE IN THERAPY(2)
- Atorvastatin calcium: PLACE IN THERAPY(3)
- Atorvastatin calcium: PLACE IN THERAPY(4)
- Atorvastatin calcium: PLACE IN THERAPY(5)
- Atorvastatin calcium: PLACE IN THERAPY(6)
- Atorvastatin calcium: PLACE IN THERAPY(7)
- Atorvastatin calcium: PLACE IN THERAPY(8)
- Atorvastatin calcium: SAFETY(1)
- Atorvastatin calcium: SAFETY(2)
- Atorvastatin calcium: SAFETY(3)
- Atorvastatin calcium: SAFETY(4)
- Atorvastatin calcium: SPECIAL PATIENT POPULATIONS Women(1)
- Atorvastatin calcium: SPECIAL PATIENT POPULATIONS Women(2)
Category: Canadian Neighbor Pharmacy
- Canadian Neighbor Pharmacy: Definitive Care for the Critically III Patients
Category: Cancer
- Factors Associated with Fatal Hemoptysis in Cancer Patients
- Factors Associated with Fatal Hemoptysis in Cancer Patients: Conclusion
- Factors Associated with Fatal Hemoptysis in Cancer Patients: Discussion
- Factors Associated with Fatal Hemoptysis in Cancer Patients: Outcome
- Factors Associated with Fatal Hemoptysis in Cancer Patients: Results
- Factors Associated with Fatal Hemoptysis in Cancer Patients: Solid Tumors
Category: Carcinomatosis
- The Value of Bronchial Washings and Bronchoalveolar Lavage in the Diagnosis of Lymphangitic Carcinomatosis
- The Value of Bronchial Washings and Bronchoalveolar Lavage in the Diagnosis of Lymphangitic Carcinomatosis: Discussion
- The Value of Bronchial Washings and Bronchoalveolar Lavage in the Diagnosis of Lymphangitic Carcinomatosis: Results
Category: Cardiology
- ATP-sensitive potassium channels and cardiac protection (part 1)
- ATP-sensitive potassium channels and cardiac protection (part 10)
- ATP-sensitive potassium channels and cardiac protection (part 11). ARRHYTHMOGENIC AND ANTIARRHYTHMIC EFFECTS OF Katp CHANNEL OPENERS
- ATP-sensitive potassium channels and cardiac protection (part 12). THE ROLE OF Katp CHANNELS IN PRECONDITIONING
- ATP-sensitive potassium channels and cardiac protection (part 13)
- ATP-sensitive potassium channels and cardiac protection (part 14) / proventil inhaler
- ATP-sensitive potassium channels and cardiac protection (part 15). SUMMARY
- ATP-sensitive potassium channels and cardiac protection (part 2)
- ATP-sensitive potassium channels and cardiac protection (part 3). PROPERTIES OF CARDIAC CHANNELS
- ATP-sensitive potassium channels and cardiac protection (part 4)
- ATP-sensitive potassium channels and cardiac protection (part 5). REGULATION OF Katp CHANNELS / ventolin 100 mcg
- ATP-sensitive potassium channels and cardiac protection (part 6). Katp CHANNEL INHIBITORS AND OPENERS
- ATP-sensitive potassium channels and cardiac protection (part 7)
- ATP-sensitive potassium channels and cardiac protection (part 8)
- ATP-sensitive potassium channels and cardiac protection (part 9)
- Doppler Evaluation of Changing Cardiac Dynamics during Cheyne-Stokes Respiration
- Doppler Evaluation of Changing Cardiac Dynamics during Cheyne-Stokes Respiration: Conclusion
- Doppler Evaluation of Changing Cardiac Dynamics during Cheyne-Stokes Respiration: Discussion
- Doppler Evaluation of Changing Cardiac Dynamics during Cheyne-Stokes Respiration: Methods
- Doppler Evaluation of Changing Cardiac Dynamics during Cheyne-Stokes Respiration: Outcome
- Doppler Evaluation of Changing Cardiac Dynamics during Cheyne-Stokes Respiration: Results
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: ANIMALS AND METHODS (part 1)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: ANIMALS AND METHODS (part 2)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: ANIMALS AND METHODS (part 3)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: DISCUSSION (part 1)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: DISCUSSION (part 2)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: DISCUSSION (part 3)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: DISCUSSION (part 4)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: Relevance to ischemic preconditioning (part 1)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: Relevance to ischemic preconditioning (part 2)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: RESULTS (part 1)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: RESULTS (part 2)
- Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: RESULTS (part 3)
Category: Cardiovascular protection
- New insights into the role of nitric oxide in cardiovascular protection (part 1)
- New insights into the role of nitric oxide in cardiovascular protection (part 10)
- New insights into the role of nitric oxide in cardiovascular protection (part 11). CONCLUSIONS
- New insights into the role of nitric oxide in cardiovascular protection (part 2) / prozac antidepressant
- New insights into the role of nitric oxide in cardiovascular protection (part 3). ANIMALS AND METHODS
- New insights into the role of nitric oxide in cardiovascular protection (part 4). RESULTS AND DISCUSSION / Buy Antidepressants Online
- New insights into the role of nitric oxide in cardiovascular protection (part 5)
- New insights into the role of nitric oxide in cardiovascular protection (part 6)
- New insights into the role of nitric oxide in cardiovascular protection (part 7)
- New insights into the role of nitric oxide in cardiovascular protection (part 8)
- New insights into the role of nitric oxide in cardiovascular protection (part 9)
Category: Cystic Fibrosis
- Antibiotic Therapy of Pulmonary Infections In Cystic Fibrosis
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Background Review of Efficacy
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Comparability of Nebulizers and Compressors
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Emergence of Intrinsically Resistant Pathogens
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Future Studies
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Inhalation Toxicology
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Microbiological indications
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Overview of Nebulizer Options
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Pharmacokinetics
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Rationale for Aerosolized Antibiotic Dosage
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Receiving Aerosolized Antibiotics
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Recommendations
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Recommendations for Addressing Microbiological Implications of Aerosolized Antibiotics
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Recommendations for Monitoring CF Patients Receiving Aerosolized Antibiotics
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Recommendations for the Use of Aerosolized Antibiotics in CF
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Safety of Aerosolized Preservative-Free 300-mg Dose of Tobramycin
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Safety of Colistin
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Studies Using Aminoglycosides
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Studies Using fi-Lactam Antibiotics
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Studies Using Polymyxins
- Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis: Ultrasonic Nebulizers
Category: Decidualization Process
- Comparative Studies on the In Vitro Decidualization Process in the Baboon (Papio anubis) and Human(1)
- Comparative Studies on the In Vitro Decidualization Process in the Baboon (Papio anubis) and Human(2)
- Comparative Studies on the In Vitro: DISCUSSION(1)
- Comparative Studies on the In Vitro: DISCUSSION(2)
- Comparative Studies on the In Vitro: DISCUSSION(3)
- Comparative Studies on the In Vitro: DISCUSSION(4)
- Comparative Studies on the In Vitro: DISCUSSION(5)
- Comparative Studies on the In Vitro: DISCUSSION(6)
- Comparative Studies on the In Vitro: MATERIALS AND METHODS(1)
- Comparative Studies on the In Vitro: MATERIALS AND METHODS(2)
- Comparative Studies on the In Vitro: MATERIALS AND METHODS(3)
- Comparative Studies on the In Vitro: MATERIALS AND METHODS(4)
- Comparative Studies on the In Vitro: MATERIALS AND METHODS(5)
- Comparative Studies on the In Vitro: MATERIALS AND METHODS(6)
- Comparative Studies on the In Vitro: RESULTS(1)
- Comparative Studies on the In Vitro: RESULTS(2)
- Comparative Studies on the In Vitro: RESULTS(3)
- Comparative Studies on the In Vitro: RESULTS(4)
- Comparative Studies on the In Vitro: RESULTS(5)
Category: Diabetes
- Medicaid Managed Care
- Medicaid Managed Care: DISCUSSION
- Medicaid Managed Care: RESEARCH DESIGN AND METHODS
- Medicaid Managed Care: RESULTS
Category: Disease
- A Case of Eruptive Collagenoma on the Left Calf

Plugin by dagondesign.com